# The Human Medicines (Amendments relating to the Windsor Framework) Regulations 2024, Regulation 23: Amendment to regulation 45F

Extent: E+W+S+N.I.

In regulation 45F (provision of information), in paragraph (1), for sub-paragraph (b) substitute—
“(b) the UK marketing authorisation holder, or, where applicable—
(i) the holder of the licence or authorisation granted by an appropriate authority responsible for the licensing of medicinal products in an approved country for import, or
(ii) the EU marketing authorisation holder,”.

---
Source: https://www.legislation.gov.uk/uksi/2024/832/regulation/23 (the official version)
Page: https://openlegislation.uk/human-medicines-amendments-relating-to-the-windsor-framework-regulations-2024/regulation-23
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.